TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Patient tolerance and satisfaction levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time-weighted average of cardiac index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hazard for needing additional boluses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median number of boluses per patient
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: mean motor improvement rates on the UPDRS‐3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased motivation to engage in treatment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction in days with gastroenteritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reduction in number of gastroenteritis episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reduced risk of having a gastroenteritis episode
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Aspiration events after swallow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Penetration events leading to aspiration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharyngeal residue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of Low Back Pain (LBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in resistance of multifidus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in thickness of multifidus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Day-long glycemic variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pupillary dilatation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative day 1 unaided visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mild pain and discomfort
Endpoint domain: Adverse events/effects
Primary endpoint: delayed first request of rescue analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: amount of morphine used
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction with the overall technique
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Surgeon's assessment of results (good to excellent)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in fat deposits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvements in skin laxity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Mean unaided 4 frequency pure-tone average (PTA) air conduction threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean air bone gap
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aided CNC word score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: International Restless Legs Rating Scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Periodic leg movement index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in proinflammatory cytokines (IL-6, IL-10, TGF-β)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction of insomnia symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lateral guidance angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in knowledge of mothers
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adaptation of breastfeeding practices
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Growth parameters of infants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PASI-90 achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PASI-100 achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak continuous glucose monitor glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence rate of nonmelanoma skin cancer (NMSC)
Endpoint domain: Adverse events/effects
Primary endpoint: dynamic balance values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of unconfirmed COVID-19 cases
Endpoint domain: Adverse events/effects
Primary endpoint: Ambulatory Sensitive Hospitalizations (ASH) rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gal-3 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thromboembolic risk (CHA2DS2-VASc score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean TRAQ scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean HbA1C value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Negative Predictive Value (NPV) of coronary CTA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Supine orthostatic hypotension (OH) prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Association of supine systolic OH with fall risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported orthostatic symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: wrist kinematics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fear
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Panic disorder symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ionized calcium concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: study dropout adjusted risk ratios
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: IL-1β, IL-8, and TNF-α levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: grade ≥ 1 anemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Total monthly mean sick leave
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: oral function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: muscle protein breakdown
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: net protein turnover
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: liver-related clinical events
Endpoint domain: Mortality/survival
Primary endpoint: regression of fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in mental health evaluated by GHQ‐12 scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in self‐efficacy evaluated by GSES scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Renal ultrasound findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: DMSA findings of renal scarring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: serum phosphate control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement in scores on the Disability‐Adapted Infant‐Toddler version of Home Observation for Measurement
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: bacterial growth rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: volume of blood transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Need for stone disintegration
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean post-operative pain VAS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean HOS (activities of daily living) scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: iHOT-12 scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: postoperative functional outcome score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in DSBs (double-strand breaks)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: mean daily step counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention at 6-months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: apolipoprotein B levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: potassium levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length of ICU stay
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Pneumonia incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: death, myocardial infarction or stroke
Endpoint domain: Mortality/survival
Primary endpoint: Association with hospitalized COVID-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Postoperative myalgia scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first required analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived quality of nursing care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: patient-reported chewing ability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Average monthly migraine days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Monthly headache days of at least moderate severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Days per month of acute headache medication use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: whole salivary RANKL/OPG ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical prognosis (Glasgow Outcome Scale and Karnofsky Performance Scale)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: effectiveness of primary care medical home
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Progression of LA structural remodeling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in moderate-vigorous physical activity (MVPA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sacrifice of the lateral lip element
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Improvement in ADHD severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subjective stress management
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Knowledge score on hypertension and diabetes
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: genital self-image
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Liver disease severity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: QLQ-C30 sleep score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Acknowledgment of advance care directives and resuscitation plans/orders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood concentrations of epinephrine, norepinephrine, and cortisol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: suppression of plasma tryptase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete shell-to-bone contact without a radiolucent line
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: AKI incidence at 30 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: BARC ≥ 3b bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Post-education state anxiety scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Readmission or death within 30 days
Endpoint domain: Mortality/survival
Primary endpoint: Emergency department visits within 30 days
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Risk for penetration and/or aspiration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perinatal composite outcome
Endpoint domain: Adverse events/effects
Primary endpoint: Maternal composite outcome
Endpoint domain: Adverse events/effects
Primary endpoint: Bladder function recovery rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Pain and functional evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ocular neuropathy
Endpoint domain: Adverse events/effects
Primary endpoint: preoperative hunger
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: weakness score on POD1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: level of Na+
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: rate of hyponatremia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: level of blood glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: percentage change in body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of responders with ≥3% reduction in body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hernia recurrence risk
Endpoint domain: Mortality/survival
Primary endpoint: N-PASS mean score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total time spent crying
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival probabilities at 28 days
Endpoint domain: Mortality/survival
Primary endpoint: Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)
Endpoint domain: Mortality/survival
Primary endpoint: Intention to consume SSBs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: urine volume output
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: warmth perception at the feet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Understanding of weight status visualization
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Likelihood of being shown a growth chart
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Calories ordered
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: HPA suppression duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost savings compared to control group
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Quality-adjusted life years (QALYs) gains
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: percent change in vBMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: CLD/Death
Endpoint domain: Mortality/survival
Primary endpoint: Blood and urine metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolic hormone levels (parathyroid hormone, 1, 25(OH)2D3)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Biochemical indicators (serum Ca, serum P, glycolipid metabolism, hepatorenal function indicators)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decreased one-year BMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rate (CPS + EG score ≤2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of CAP episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of LRTI episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: LRTI-related antibiotic use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean Ca level in hair
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean As concentration in hair
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean Pb concentration in hair
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of low-risk localized tumors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of metastatic tumors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: peak pVO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Brief Psychiatric Rating Scale positive symptom item score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immunogenicity of PCV13
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Safety of PCV13
Endpoint domain: Adverse events/effects
Primary endpoint: Maximal Fat Oxidation (MFO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Risk of readmission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: continuity of care disruption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: worry and anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: NRS score variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KPS score variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain remission rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in lower limb motor functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective global satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Provider-specific HCAHPS scores
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: CEL occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: in-hospital pulmonary embolism (PE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: intestinal flora
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: host metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Aortic pulse‐wave velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Subjective cosmetic success rate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: RRS total scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PLV in the DMN
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of neuropsychiatric adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of fear
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: self-perceived difficulties in basic ADL
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: T-WOMAC score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PCOLCE (enzymatic cleavage of type I procollagen)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: PLA2G7 (systemic marker of arterial inflammation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Integrin subunit alpha M (integrin adhesive function)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: incidence of transfusion
Endpoint domain: Adverse events/effects
Primary endpoint: Response rate at 3-month post-intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Total decisional conflicts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient assessment of chronic illness care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: primary bleeding outcomes
Endpoint domain: Adverse events/effects
Primary endpoint: Medians of morphine bolus consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: CPK-MB at second post-operative
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes